PolypStim

PolypStim is a medical technology company and a portfolio startup of Leonhardt's Launchpads, focused on developing bioelectric therapies for the non-invasive treatment and removal of polyps, fibroids, and cysts. The company utilizes proprietary bioelectric signaling sequences designed to induce apoptosis in abnormal growths, disrupt cellular communication, and stimulate an immune response to clear the tissue. PolypStim's technology aims to provide a non-surgical alternative to traditional polypectomy and surgical excision. Currently in the pre-clinical stage, the company is part of a broader suite of organ-regeneration and recovery innovations developed by Leonhardt Ventures.